In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Drug delivery start-up Lyndra brings in $23mm through Series A round

Executive Summary

Lyndra Inc. (develops sustained-release oral dosage forms) closed a $23mm Series A round led by Polaris Partners. Quark Venture, GF Securities, Yonghua Capital, Healthlink Capital, Partners Healthcare, and Suffolk Equity also participated.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies